Intrinsic mitral valve alterations in hypertrophic cardiomyopathy sarcomere mutation carriers
Open Access
- 26 July 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 19 (10) , 1109-1116
Abstract
Mitral valve (MV) abnormalities are recognized features of hypertrophic cardiomyopathy (HCM), and there is preliminary evidence suggesting they are intrinsic phenotypic manifestations of sarcomere mutations, present in mutation carriers without left ventricular (LV) hypertrophy (subclinical HCM). However, further study is required to characterize the nature of these changes and their functional impact. Thus, we performed comprehensive echocardiographic analysis of MV structure and function on a genotyped population. MV and papillary muscle echocardiographic parameters were measured in 192 genotyped individuals, including 50 overt HCM, 79 subclinical HCM, and 63 mutation-negative, healthy relatives as normal controls. Compared to controls, subclinical HCM subjects had elongated anterior MV leaflets relative to LV end-diastolic volume index (0.57 ± 0.02 vs. 0.51 ± 0.02 mm/mL/m2, P = 0.013) and anteriorly displaced papillary muscles [decreased papillary-septal separation (31.1 ± 0.7 vs. 34.2 ± 0.9 mm, P = 0.004) and relative antero-posterior position ratio of the papillary muscles (0.67 ± 0.01 vs. 0.71 ± 0.01, P = 0.011]. Similar findings were identified comparing overt HCM to controls. These MV changes were associated with an increased prevalence of systolic anterior motion (SAM) of the MV amongst subclinical HCM subjects. Sarcomere mutations are associated with primary abnormalities of the MV apparatus, specifically excess anterior leaflet length relative to LV cavity size and anterior displacement of the papillary muscles; both features predisposing to SAM. These abnormalities appear to be early phenotypic consequences of sarcomere mutations, observed in mutation carriers with normal LV wall thickness.Keywords
Funding Information
- National Heart, Lung, and Blood Institute
- National Institutes of Health (K23 HL078901, 1P20HL101408)
- NIH
This publication has 27 references indexed in Scilit:
- The Burden of Early Phenotypes and the Influence of Wall Thickness in Hypertrophic Cardiomyopathy Mutation CarriersJAMA Cardiology, 2017
- The embryological basis of subclinical hypertrophic cardiomyopathyScientific Reports, 2016
- Morphological and functional abnormalities pattern in hypertrophy-free HCM mutation carriers detected with echocardiographyThe International Journal of Cardiovascular Imaging, 2016
- Mild Expression of Mitral Valve Prolapse in the Framingham Offspring: Expanding the Phenotypic SpectrumJournal of the American Society of Echocardiography, 2014
- Papillary Muscle Insertion Directly into the Anterior Mitral Leaflet in Hypertrophic Cardiomyopathy, Its Identification and Cause of Outflow Obstruction by Cardiac Magnetic Resonance Imaging, and Its Surgical ManagementThe American Journal of Cardiology, 2013
- The Mitral Valve in Hypertrophic CardiomyopathyJournal of Cardiovascular Translational Research, 2011
- The many facets of the matricelluar protein periostin during cardiac development, remodeling, and pathophysiologyJournal of Cell Communication and Signaling, 2009
- Mitral Valve Abnormalities in Hypertrophic Cardiomyopathy: Echocardiographic Features and Surgical OutcomesThe Annals of Thoracic Surgery, 2008
- Periostin regulates atrioventricular valve maturationDevelopmental Biology, 2008
- Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of CardiologyJournal of the American Society of Echocardiography, 2005